Finance
Results: 28237-28248 of 35769

Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories

Elda River Capital Management Completes Successful Spin-Out and Launch of Independent Real Assets Investment Firm






